Purification and Characterization of Botulinum Neurotoxin FA from a Genetically Modified Clostridium botulinum Strain.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 27303710)

Published in mSphere on February 24, 2016

Authors

Sabine Pellett1, William H Tepp1, Marite Bradshaw1, Suzanne R Kalb2, Janet K Dykes3, Guangyun Lin1, Erin M Nawrocki1, Christina L Pier1, John R Barr2, Susan E Maslanka3, Eric A Johnson1

Author Affiliations

1: Department of Bacteriology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
2: National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
3: National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Articles cited by this

Botulinum toxin as a biological weapon: medical and public health management. JAMA (2001) 9.18

Human botulism immune globulin for the treatment of infant botulism. N Engl J Med (2006) 5.67

Genetic diversity among Botulinum Neurotoxin-producing clostridial strains. J Bacteriol (2006) 4.75

The ClosTron: a universal gene knock-out system for the genus Clostridium. J Microbiol Methods (2007) 4.20

A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins. J Infect Dis (2013) 3.75

The ClosTron: Mutagenesis in Clostridium refined and streamlined. J Microbiol Methods (2009) 3.16

Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization. Infect Immun (2005) 3.06

Molecular characterization of a novel botulinum neurotoxin type H gene. J Infect Dis (2013) 3.00

Cleavage of members of the synaptobrevin/VAMP family by types D and F botulinal neurotoxins and tetanus toxin. J Biol Chem (1994) 2.00

Botulinum neurotoxins: genetic, structural and mechanistic insights. Nat Rev Microbiol (2014) 1.89

Detection of type A, B, and E botulism neurotoxin genes in Clostridium botulinum and other Clostridium species by PCR: evidence of unexpressed type B toxin genes in type A toxigenic organisms. J Clin Microbiol (1994) 1.77

Infant botulism. Annu Rev Med (1980) 1.76

A Novel Botulinum Neurotoxin, Previously Reported as Serotype H, Has a Hybrid-Like Structure With Regions of Similarity to the Structures of Serotypes A and F and Is Neutralized With Serotype A Antitoxin. J Infect Dis (2015) 1.65

Studies on strain 84 of Clostridium botulinum. Zentralbl Bakteriol Orig (1970) 1.60

Genetic diversity within Clostridium botulinum serotypes, botulinum neurotoxin gene clusters and toxin subtypes. Curr Top Microbiol Immunol (2013) 1.58

Clostridium botulinum in the post-genomic era. Food Microbiol (2010) 1.41

A neuronal cell-based botulinum neurotoxin assay for highly sensitive and specific detection of neutralizing serum antibodies. FEBS Lett (2007) 1.40

Investigational heptavalent botulinum antitoxin (HBAT) to replace licensed botulinum antitoxin AB and investigational botulinum antitoxin E. MMWR Morb Mortal Wkly Rep (2010) 1.40

Extraction and inhibition of enzymatic activity of botulinum neurotoxins/A1, /A2, and /A3 by a panel of monoclonal anti-BoNT/A antibodies. PLoS One (2009) 1.35

The role of sulfhydryl groups in the activity of type A botulinum toxin. Biochim Biophys Acta (1970) 1.33

Mosaic structures of neurotoxins produced from Clostridium botulinum types C and D organisms. Biochim Biophys Acta (1996) 1.27

Comparison of the primary rat spinal cord cell (RSC) assay and the mouse bioassay for botulinum neurotoxin type A potency determination. J Pharmacol Toxicol Methods (2010) 1.21

Novel application of human neurons derived from induced pluripotent stem cells for highly sensitive botulinum neurotoxin detection. Toxicol Sci (2012) 1.21

Characterization of six type A strains of Clostridium botulinum that contain type B toxin gene sequences. FEMS Microbiol Lett (2004) 1.21

Genetic characterization of Clostridium botulinum type A containing silent type B neurotoxin gene sequences. J Biol Chem (1996) 1.15

Atypical toxin variant of Clostridium botulinum type B associated with infant botulism. J Clin Microbiol (1981) 1.15

Discovery of a novel enzymatic cleavage site for botulinum neurotoxin F5. FEBS Lett (2011) 1.13

Dual toxin-producing strain of Clostridium botulinum type Bf isolated from a California patient with infant botulism. J Clin Microbiol (2004) 1.12

Recombinant holotoxoid vaccine against botulism. Infect Immun (2007) 1.09

Conjugative botulinum neurotoxin-encoding plasmids in Clostridium botulinum. PLoS One (2010) 1.08

Infantile botulism. Arch Dis Child (1989) 1.02

Draft Genome Sequence of Bivalent Clostridium botulinum Strain IBCA10-7060, Encoding Botulinum Neurotoxin B and a New FA Mosaic Type. Genome Announc (2014) 1.01

Clostridium botulinum subtype Ba. Zentralbl Bakteriol Mikrobiol Hyg A (1984) 1.01

Clostridium botulinum strain Af84 contains three neurotoxin gene clusters: bont/A2, bont/F4 and bont/F5. PLoS One (2013) 1.00

Functional characterization of botulinum neurotoxin serotype H as a hybrid of known serotypes F and A (BoNT F/A). Anal Chem (2015) 1.00

Three enzymatically active neurotoxins of Clostridium botulinum strain Af84: BoNT/A2, /F4, and /F5. Anal Chem (2014) 0.95

Novel application of an in vitro technique to the detection and quantification of botulinum neurotoxin antibodies. J Immunol Methods (2004) 0.94

New strains of Clostridium botulinum subtype Af. Zentralbl Bakteriol Orig A (1978) 0.94

[Serological study of Clostridium botulinum type A and strain 84 toxins]. Rev Latinoam Microbiol (1972) 0.92

Colony immunoblot assay of botulinal toxin. Appl Environ Microbiol (1993) 0.92

Medical aspects of bio-terrorism. Toxicon (2013) 0.92

Construction of a nontoxigenic Clostridium botulinum strain for food challenge studies. Appl Environ Microbiol (2009) 0.91

On botulinum neurotoxin variability. MBio (2015) 0.87

Holotoxin Activity of Botulinum Neurotoxin Subtype A4 Originating from a Nontoxigenic Clostridium botulinum Expression System. Appl Environ Microbiol (2014) 0.86

The detection of a deletion in the type B neurotoxin gene of Clostridium botulinum A(B) strains by a two-step PCR. Lett Appl Microbiol (1998) 0.85

Improved detection methods by genetic and immunological techniques for botulinum C/D and D/C mosaic neurotoxins. Vet Microbiol (2012) 0.82

Production of recombinant botulism antigens: a review of expression systems. Anaerobe (2014) 0.82

Immunoprecipitation of native botulinum neurotoxin complexes from Clostridium botulinum subtype A strains. Appl Environ Microbiol (2014) 0.80

[Identification of strain B 657 of Clostridium botulinum]. Rev Argent Microbiol (1983) 0.80